![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: QTRT1 |
Gene summary for QTRT1 |
![]() |
Gene information | Species | Human | Gene symbol | QTRT1 | Gene ID | 81890 |
Gene name | queuine tRNA-ribosyltransferase catalytic subunit 1 | |
Gene Alias | FP3235 | |
Cytomap | 19p13.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q71RF8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
81890 | QTRT1 | C09 | Human | Oral cavity | OSCC | 2.27e-12 | 4.13e-01 | 0.1431 |
81890 | QTRT1 | LN22 | Human | Oral cavity | OSCC | 1.96e-09 | 1.05e+00 | 0.1733 |
81890 | QTRT1 | LN46 | Human | Oral cavity | OSCC | 8.54e-13 | 6.91e-01 | 0.1666 |
81890 | QTRT1 | LP15 | Human | Oral cavity | LP | 5.12e-08 | 1.16e+00 | 0.2174 |
81890 | QTRT1 | LP17 | Human | Oral cavity | LP | 2.95e-07 | 9.68e-01 | 0.2349 |
81890 | QTRT1 | SYSMH2 | Human | Oral cavity | OSCC | 1.08e-13 | 5.16e-01 | 0.2326 |
81890 | QTRT1 | SYSMH3 | Human | Oral cavity | OSCC | 5.77e-28 | 6.66e-01 | 0.2442 |
81890 | QTRT1 | SYSMH4 | Human | Oral cavity | OSCC | 1.46e-02 | 1.27e-01 | 0.1226 |
81890 | QTRT1 | SYSMH5 | Human | Oral cavity | OSCC | 3.19e-03 | 9.16e-02 | 0.0647 |
81890 | QTRT1 | SYSMH6 | Human | Oral cavity | OSCC | 4.38e-03 | 2.19e-01 | 0.1275 |
81890 | QTRT1 | P1_cSCC | Human | Skin | cSCC | 2.80e-22 | 8.71e-01 | 0.0292 |
81890 | QTRT1 | P2_cSCC | Human | Skin | cSCC | 1.21e-20 | 6.66e-01 | -0.024 |
81890 | QTRT1 | P4_cSCC | Human | Skin | cSCC | 9.61e-18 | 5.50e-01 | -0.00290000000000005 |
81890 | QTRT1 | P10_cSCC | Human | Skin | cSCC | 4.36e-14 | 6.01e-01 | 0.1017 |
81890 | QTRT1 | male-WTA | Human | Thyroid | PTC | 3.64e-15 | 5.52e-02 | 0.1037 |
81890 | QTRT1 | PTC01 | Human | Thyroid | PTC | 5.66e-27 | 2.58e-01 | 0.1899 |
81890 | QTRT1 | PTC03 | Human | Thyroid | PTC | 5.78e-05 | 1.40e-01 | 0.1784 |
81890 | QTRT1 | PTC04 | Human | Thyroid | PTC | 7.60e-17 | 1.46e-01 | 0.1927 |
81890 | QTRT1 | PTC05 | Human | Thyroid | PTC | 3.63e-09 | 4.27e-01 | 0.2065 |
81890 | QTRT1 | PTC06 | Human | Thyroid | PTC | 4.04e-27 | 4.74e-01 | 0.2057 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003447015 | Esophagus | ESCC | ncRNA processing | 300/8552 | 395/18723 | 3.09e-35 | 3.26e-32 | 300 |
GO:003466012 | Esophagus | ESCC | ncRNA metabolic process | 346/8552 | 485/18723 | 4.35e-31 | 2.51e-28 | 346 |
GO:00080333 | Esophagus | ESCC | tRNA processing | 92/8552 | 127/18723 | 7.83e-10 | 1.93e-08 | 92 |
GO:00063992 | Esophagus | ESCC | tRNA metabolic process | 122/8552 | 179/18723 | 9.03e-10 | 2.19e-08 | 122 |
GO:00094512 | Esophagus | ESCC | RNA modification | 114/8552 | 167/18723 | 2.76e-09 | 6.04e-08 | 114 |
GO:00064002 | Esophagus | ESCC | tRNA modification | 62/8552 | 90/18723 | 7.02e-06 | 7.04e-05 | 62 |
GO:00344701 | Liver | Cirrhotic | ncRNA processing | 158/4634 | 395/18723 | 1.09e-11 | 6.96e-10 | 158 |
GO:00346603 | Liver | Cirrhotic | ncRNA metabolic process | 173/4634 | 485/18723 | 3.64e-08 | 1.21e-06 | 173 |
GO:00344702 | Liver | HCC | ncRNA processing | 293/7958 | 395/18723 | 4.26e-38 | 6.76e-35 | 293 |
GO:00346601 | Liver | HCC | ncRNA metabolic process | 332/7958 | 485/18723 | 1.48e-31 | 7.80e-29 | 332 |
GO:0008033 | Liver | HCC | tRNA processing | 87/7958 | 127/18723 | 2.66e-09 | 7.23e-08 | 87 |
GO:0006399 | Liver | HCC | tRNA metabolic process | 108/7958 | 179/18723 | 1.07e-06 | 1.59e-05 | 108 |
GO:0009451 | Liver | HCC | RNA modification | 101/7958 | 167/18723 | 2.02e-06 | 2.78e-05 | 101 |
GO:0006400 | Liver | HCC | tRNA modification | 60/7958 | 90/18723 | 3.09e-06 | 4.09e-05 | 60 |
GO:00344709 | Oral cavity | OSCC | ncRNA processing | 263/7305 | 395/18723 | 4.38e-29 | 2.78e-26 | 263 |
GO:00346605 | Oral cavity | OSCC | ncRNA metabolic process | 296/7305 | 485/18723 | 2.94e-23 | 6.65e-21 | 296 |
GO:00080332 | Oral cavity | OSCC | tRNA processing | 78/7305 | 127/18723 | 2.56e-07 | 4.00e-06 | 78 |
GO:00063991 | Oral cavity | OSCC | tRNA metabolic process | 101/7305 | 179/18723 | 1.65e-06 | 2.15e-05 | 101 |
GO:00094511 | Oral cavity | OSCC | RNA modification | 95/7305 | 167/18723 | 2.05e-06 | 2.62e-05 | 95 |
GO:00064001 | Oral cavity | OSCC | tRNA modification | 53/7305 | 90/18723 | 1.04e-04 | 7.70e-04 | 53 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
QTRT1 | SNV | Missense_Mutation | c.629N>A | p.Arg210Gln | p.R210Q | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
QTRT1 | SNV | Missense_Mutation | novel | c.405N>C | p.Glu135Asp | p.E135D | Q9BXR0 | protein_coding | tolerated(0.32) | benign(0.035) | TCGA-DG-A2KM-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
QTRT1 | SNV | Missense_Mutation | rs377094295 | c.1081C>T | p.Arg361Cys | p.R361C | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
QTRT1 | SNV | Missense_Mutation | novel | c.398N>T | p.Gly133Val | p.G133V | Q9BXR0 | protein_coding | deleterious(0) | benign(0.312) | TCGA-VS-A9UJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
QTRT1 | SNV | Missense_Mutation | c.629N>A | p.Arg210Gln | p.R210Q | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CM-6162-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
QTRT1 | SNV | Missense_Mutation | c.319N>A | p.Gly107Ser | p.G107S | Q9BXR0 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
QTRT1 | SNV | Missense_Mutation | novel | c.317G>T | p.Ser106Ile | p.S106I | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
QTRT1 | SNV | Missense_Mutation | rs747033265 | c.676G>A | p.Ala226Thr | p.A226T | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AJ-A3BH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
QTRT1 | SNV | Missense_Mutation | c.863N>A | p.Arg288His | p.R288H | Q9BXR0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
QTRT1 | SNV | Missense_Mutation | rs756496433 | c.1021N>A | p.Ala341Thr | p.A341T | Q9BXR0 | protein_coding | deleterious(0.04) | possibly_damaging(0.756) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |